Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polomar Health ServicesPMHS 33 Equity-to-Asset is -2.41 as of Mar. 2026. GuruFocus rates PMHS with a GF Score™ of 33/100 and a GF Value™ of $12.65 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 97.22% on this metric.
The historical rank and industry rank for Polomar Health Services's Equity-to-Asset or its related term are showing as below:
PMHS'
s Equity-to-Asset Range Over the Past 10 Years
Min: -3.13 Med: 0.84 Max: 0.95
Current: -2.41
During the past 7 years, the highest Equity to Asset Ratio of Polomar Health Services was 0.95. The lowest was -3.13. And the median was 0.84.
PMHS's Equity-to-Asset is ranked worse than 97.22% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs PMHS: -2.41
Polomar Health Services (OTCPK:PMHS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Polomar Health Services Equity-to-Asset Related Terms
Polomar Health Services Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMHS vs DHTI, RDGT, BLMH: Equity-to-Asset Comparison
For the Pharmaceutical Retailers subindustry, Polomar Health Services's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's Equity-to-Asset falls into.
Polomar Health Services Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Polomar Health Services's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services (PMHS) has a Equity-to-Asset of -2.41 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #665 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 97.2%.
Is Polomar Health Services' Equity-to-Asset too high?
Polomar Health Services' current Equity-to-Asset is -2.41. Based on the distribution chart, Polomar Health Services ranks #665 out of 684 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Polomar Health Services has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' Equity-to-Asset compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #665 out of 684 companies for Equity-to-Asset. This places Polomar Health Services in the lower half of its industry. The industry median Equity-to-Asset is 0.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current Equity-to-Asset is -2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.65, compared to a current price of $0.14 — trading 98.9% below its estimated fair value. The current Equity-to-Asset is -2.41. Polomar Health Services' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current Equity-to-Asset is -2.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.14 is trading 98.9% below its estimated GF Value™ of $12.65.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
Equity-to-Asset: -2.41
GF Value™: $12.65 vs. price of $0.14 (98.9% below fair value)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
33GF Score
Get the complete analysis for PMHS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
